Rapid Micro Biosystems, Inc. Deferred Federal Income Tax Expense (Benefit)
Rapid Micro Biosystems, Inc. (RPID) reported Deferred Federal Income Tax Expense (Benefit) of $10.03 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-12.
Financial Statements › Expense Statement › Income Tax
us-gaap:DeferredFederalIncomeTaxExpenseBenefit · last filed 2026-03-12
- Rapid Micro Biosystems, Inc. deferred federal income tax expense (benefit) for fiscal 2025 was $10.03M, a 1.91% increase from fiscal 2024.
- Rapid Micro Biosystems, Inc. deferred federal income tax expense (benefit) for fiscal 2024 was $9.85M, a 11.91% decline from fiscal 2023.
- Rapid Micro Biosystems, Inc. deferred federal income tax expense (benefit) for fiscal 2023 was $11.18M.
- Rapid Micro Biosystems, Inc. deferred federal income tax expense (benefit) for fiscal 2022 was -$13.35M, a 178.06% decline from fiscal 2021.
| Period end | Deferred Federal Income Tax Expense (Benefit) 12 month | Deferred Federal Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2025-12-31 | $10.03M 10-K · filed 2026-03-12 | |
| 2024-12-31 | $9.85M 10-K · filed 2026-03-12 | |
| 2023-12-31 | $11.18M 10-K · filed 2025-02-28 | -$11.18M 10-K · filed 2024-03-01 |
| 2022-12-31 | -$13.35M 10-K · filed 2024-03-01 | |
| 2021-12-31 | $17.10M 10-K · filed 2023-03-10 | |
| 2020-12-31 | -$7.46M 10-K · filed 2022-03-24 |